Bicycle Therapeutics (BCYC) PT Raised to $40 at Canaccord Genuity
Tweet Send to a Friend
Canaccord Genuity analyst Arlinda Lee raised the price target on Bicycle Therapeutics (NASDAQ: BCYC) to $40.00 (from $36.00) while maintaining ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
